Clinical trial Recruiting at 1 site Interventional Ages 18 to 64

Understanding and reducing suicidal behavior in bipolar disorder patients

Official title: Suicidal Behavior in Patients Diagnosed With Bipolar Disorder: The Roles of Biological and Childhood and Adult Environmental Risk Factors

Run by Emory University · NCT02604277 · Data updated 2026-11-12

This study is testing a 6-week group program with different therapies to see if it can help people with bipolar disorder reduce suicidal thoughts and improve their quality of life.

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment130 (estimated)
SponsorEmory University
Academic / other
Locations1 site (Atlanta, Georgia)
StatusRecruiting
StartedJanuary 2016
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJanuary 7, 2026
Trial IDNCT02604277 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are English-speaking individuals diagnosed with Bipolar Disorder who can provide informed consent.

Probably not a fit

Patients with cognitive impairments, acute psychosis, or a history of schizophrenia spectrum disorder may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the environmental and psychological factors influencing suicidality in individuals diagnosed with Bipolar Disorder. It aims to identify effective treatments to reduce suicidal behavior and enhance quality of life through a 6-week group-based intervention program. The program includes various therapeutic approaches such as Interpersonal and Social Rhythm Therapy, Bipolar-Specific Cognitive Behavioral Therapy, and Mindfulness-Based Stress Reduction, focusing on coping strategies and understanding bipolar disorder.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies that significantly reduce suicidal behavior in patients with Bipolar Disorder.

How similar studies have gone: Other studies have shown promise in using similar therapeutic approaches to address suicidality in bipolar disorder, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* English speaking
* Diagnosis of Bipolar Disorder (BD)
* Able to provide written informed consent

Exclusion Criteria:

* Cognitive impairments
* Acutely psychotic
* Medically unstable
* History of schizophrenia spectrum disorder
* History of mood incongruent psychotic symptoms
* History of primary substance disorder
* History of primary organic disease and/or dementia

Where it's running

  • Grady Health System
    Atlanta, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.